Experimental Study of 103pd Stents for Preventing the Restenosis of Biliary Duct

高沁怡,何贵金,舒强,陆相东,李亚明,裴著果,许书河

DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2004.06.016

2004-01-01

Abstract:Objective To explore the feasibility of preventing biliary duct restenosis with the stent treated with 103Pd and to elucidate the mechanisms of the inhibition of the smooth muscle cell proliferation and the increase of apoptosis. Methods The experimental dogs were randomly divided into common-stent group and 103Pd stent group, each of 6 animals. Pathohistology, cell apoptosis, immunohistochemistry for proliferating cell nuclear antigen (PCNA), the expression of gene p53 by in situs hybridization, the test of the peripheral blood and measurement of radiation of tissue around the stent were studied. Results The utmost intimal thickness of biliary duct in the 103Pd stent group was found to be obviously less compared to that in common-stent group after 30 d, the percentages of the stenosis of the biliary duct were (54.73±21.64)% and (17.61±14.52)%, respectively, there was a significant difference between two groups (P0.01); the circumference and area of biliary duct lumen were obviously larger compared to that in the common-stent group (P0.01). The expression of gene p53 of biliary tissue increased in the 103Pd stent group, and decreased in the common-stent group; the expression of PCNA of biliary smooth muscle cells of 103Pd group was weaker compared with that in the common-group. Conclusion 103Pd stent may inhibit the proliferation of smooth muscle cells and prevent the restenosis of biliary duct.